Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5286 USD | -0.94% | -6.85% | -58.05% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.05% | 29.02M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock BioVie Inc. - Nasdaq
- News BioVie Inc.
- BioVie : B. Riley Raises BioVie's PT to $50 from $47 On Liver, Neurodegenerative, and Oncology Pipeline, Keeps Buy Rating